StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GROBTEA.NS$898.90+0.27%
Fair $898.90+0.0%

GROBTEA.NS

The Grob Tea Company Limited

Consumer Defensive / Farm ProductsNSE

$898.90

+2.45 (+0.27%)

Fairly Valued+0.0%Fair Value $898.90Fund rank 24/100 · Data gapFallback financials|
SA 24/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-61.7M · quality 39.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 8/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

24/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · GROBTEA.NSLocal privado en este navegador · The Grob Tea Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.0B

P/E

18.2x

↑

EV/EBITDA

11.9x

↑

ROE

6.2%

↓

Gross Margin

83.4%

↑

Debt/Equity

0.57

↑
52-Week Range$899
$805$1360

TradingView lightweight chart

GROBTEA.NS price, volumen y niveles de valoración

Último $898.90Periodo +140.2%
Fair value: $898.90

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+3.9%

FCF CAGR

—

FCF margin

-10.2%

FCF / Net income

-2.02x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.14B · net income $57.5M · FCF $-116.2M

2023-FY → 2026-FY

Gross margin

83.4%-0.6% pts

Operating margin

2.4%+1.7% pts

Net margin

5.0%+4.4% pts

FCF margin

-10.2%-6.2% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$1.14B$1.14B$1.19B$994.6M$1.02B
Net Income$57.5M$57.5M$100.6M$-73000.00$6.0M
EBITDA$131.7M$131.7M$169.9M$52.1M$73.0M
EPS——86.52-0.065.20
Gross Margin83.4%83.4%83.3%86.7%84.0%
Operating Margin2.4%2.4%4.9%-2.8%0.7%
Net Margin5.0%5.0%8.5%-0.0%0.6%
Balance Sheet
Debt/Equity0.570.570.210.120.15
Cash Flow
Free Cash Flow$-116.2M$-116.2M$90.2M$-61.7M$-40.0M
Returns
ROE6.2%6.2%11.5%-0.0%0.8%
Valuation
P/E18.1718.1710.65—144.42
EV/EBITDA11.9411.947.3622.1513.55
P/B1.131.131.221.351.12
Growth & Yield
Revenue Growth-3.5%-3.5%19.2%-2.5%—
EPS Growth——144300.0%-101.2%—
Dividend Yield0.2%0.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -9.7%

Total return

-9.7%

Start / end P/E

n/dx → n/dx

EPS bridge

86.52 → n/d

Residual

-9.9%

EPS growthn/d
Multiple reratingn/d
Dividend+0.2%
Residual / FX / buybacks / cross-term-9.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.